RA Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$87.2M	Hold	10,860,977	–	–	0.92%	24
2025 Q4	$127M	Hold	10,860,977	–	–	1.3%	18
2025 Q3	$109M	Hold	10,860,977	–	–	1.35%	20
2025 Q2	$190M	Hold	10,860,977	–	–	3.19%	8
2025 Q1	$137M	Hold	10,860,977	–	–	2.28%	11
2024 Q4	$115M	Hold	10,860,977	–	–	1.52%	17
2024 Q3	$157M	Hold	10,860,977	–	–	1.82%	15
2024 Q2	$92.4M	Hold	10,860,977	–	–	1.22%	22
2024 Q1	$111M	Buy	10,860,977 +1,401,299	+15%	+$10.4M	1.41%	22
2023 Q4	$51.8M	Hold	9,459,678	–	–	0.81%	30
2023 Q3	$35.8M	Buy	9,459,678 +6,450,000	+214%	+$42.3M	0.7%	39
2023 Q2	$20.2M	Hold	3,009,678	–	–	0.38%	43
2023 Q1	$19.6M	Hold	3,009,678	–	–	0.44%	45
2022 Q4	$25.7M	Buy	+3,009,678	New	+$19.5M	0.52%	44
2022 Q1	–	Sell	-1,742,186	Closed	-$11.6M	–	104
2021 Q4	$11.6M	Hold	1,742,186	–	–	0.2%	78
2021 Q3	$17.4M	Hold	1,742,186	–	–	0.24%	66
2021 Q2	$53.8M	Hold	1,742,186	–	–	0.86%	37
2021 Q1	$76M	Hold	1,742,186	–	–	1.15%	27
2020 Q4	$80.7M	Buy	+1,742,186	New	+$58.2M	1.13%	27